Skip to main content
Log in

US FDA black box warning alters antidepressant prescribing

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Lineberry TW, Bostwick JM, Beebe TJ, Decker PA.Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening Pandora's suicide box. Mayo Clinic Proceedings 82: 518-520, No. 4, Apr 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

US FDA black box warning alters antidepressant prescribing. Pharmacoecon. Outcomes News 529, 11 (2007). https://doi.org/10.2165/00151234-200705290-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00031

Keywords

Navigation